Matches in SemOpenAlex for { <https://semopenalex.org/work/W2123955897> ?p ?o ?g. }
- W2123955897 endingPage "748" @default.
- W2123955897 startingPage "737" @default.
- W2123955897 abstract "Most current classifications of lymphoid neoplasms define the tumors based on the cell of origin, phenotype, genetic abnormalities, and clinical features. Here it is proposed that human lymphocytic tumors can be categorized based on the propensity and capacity of the tumor cells to undergo apoptosis. The first category is defined by malignant cells that are resistant to apoptosis due to expression of anti-apoptotic factors such as bcl-2 and cellular inhibitors of apoptosis (IAPs). These tumors would include CLL and follicular lymphomas, as well as some malignancies in which the tumor cells are infected by viruses that co-opt cell survival pathways, such as human T-cell leukemia/lymphoma virus (HTLV)-1. The second category, in which the malignant cells are apoptosis-prone, would include tumors arising in the context of impaired cytotoxic T-cell function. These neoplasms would include some human immunodeficiency virus (HIV)-related lymphomas such as Burkitt's lymphoma, and post-transplantation lymphomas. The third category would include neoplasms of intermediate sensitivity to apoptosis, some of which are associated with infection such as mucosa-associated lymphoid tissue (MALT) lymphomas of the stomach. Although this classification is tentative, it should evolve in parallel with our understanding of pathogenic mechanisms in lymphoid neoplasia, and provides a novel framework with which to consider the appropriateness of specific therapeutic strategies. Distinctions among lymphocytic tumors in terms of the likelihood of response to therapies such as antisense to bcl-2 related proteins, inhibitors of NF-kappa B activity, and new approaches aimed at bolstering the host's immune response, would cross standard classifications based on the T or B-cell origin of the tumor cells." @default.
- W2123955897 created "2016-06-24" @default.
- W2123955897 creator A5087862524 @default.
- W2123955897 date "2002-01-01" @default.
- W2123955897 modified "2023-09-26" @default.
- W2123955897 title "Apoptosis in Lymphocytic Leukemias and Lymphomas" @default.
- W2123955897 cites W1492263161 @default.
- W2123955897 cites W1492606093 @default.
- W2123955897 cites W1499230593 @default.
- W2123955897 cites W1500271849 @default.
- W2123955897 cites W1504653733 @default.
- W2123955897 cites W1565408903 @default.
- W2123955897 cites W1602356478 @default.
- W2123955897 cites W1644794975 @default.
- W2123955897 cites W180295822 @default.
- W2123955897 cites W1888783223 @default.
- W2123955897 cites W1892343557 @default.
- W2123955897 cites W1947622855 @default.
- W2123955897 cites W196287517 @default.
- W2123955897 cites W1965217295 @default.
- W2123955897 cites W1965609745 @default.
- W2123955897 cites W1970584505 @default.
- W2123955897 cites W1976088592 @default.
- W2123955897 cites W1977635228 @default.
- W2123955897 cites W1978559408 @default.
- W2123955897 cites W1979435648 @default.
- W2123955897 cites W1979995768 @default.
- W2123955897 cites W1980365354 @default.
- W2123955897 cites W1981960541 @default.
- W2123955897 cites W1982133573 @default.
- W2123955897 cites W1983398917 @default.
- W2123955897 cites W1988355439 @default.
- W2123955897 cites W1989867940 @default.
- W2123955897 cites W1990073813 @default.
- W2123955897 cites W1994228428 @default.
- W2123955897 cites W1999197294 @default.
- W2123955897 cites W2001846218 @default.
- W2123955897 cites W2004520528 @default.
- W2123955897 cites W2008898220 @default.
- W2123955897 cites W2012173926 @default.
- W2123955897 cites W2013364831 @default.
- W2123955897 cites W2015788325 @default.
- W2123955897 cites W2017963311 @default.
- W2123955897 cites W2018544683 @default.
- W2123955897 cites W2021690185 @default.
- W2123955897 cites W2023400811 @default.
- W2123955897 cites W2025328966 @default.
- W2123955897 cites W2028577534 @default.
- W2123955897 cites W2036279452 @default.
- W2123955897 cites W2036789689 @default.
- W2123955897 cites W2038426029 @default.
- W2123955897 cites W2040470926 @default.
- W2123955897 cites W2045164993 @default.
- W2123955897 cites W2049052619 @default.
- W2123955897 cites W2051994734 @default.
- W2123955897 cites W2063756112 @default.
- W2123955897 cites W2066027952 @default.
- W2123955897 cites W2069631638 @default.
- W2123955897 cites W2072344463 @default.
- W2123955897 cites W2074066818 @default.
- W2123955897 cites W2078161165 @default.
- W2123955897 cites W2081332505 @default.
- W2123955897 cites W2082575834 @default.
- W2123955897 cites W2090620583 @default.
- W2123955897 cites W2106877484 @default.
- W2123955897 cites W2107202569 @default.
- W2123955897 cites W2112016055 @default.
- W2123955897 cites W2113578923 @default.
- W2123955897 cites W2117291755 @default.
- W2123955897 cites W2122095304 @default.
- W2123955897 cites W2122275228 @default.
- W2123955897 cites W2124106713 @default.
- W2123955897 cites W2128663983 @default.
- W2123955897 cites W2131598459 @default.
- W2123955897 cites W2135506398 @default.
- W2123955897 cites W2138804143 @default.
- W2123955897 cites W2139928557 @default.
- W2123955897 cites W2144092964 @default.
- W2123955897 cites W2146416883 @default.
- W2123955897 cites W2155557164 @default.
- W2123955897 cites W2157549025 @default.
- W2123955897 cites W2158708535 @default.
- W2123955897 cites W2161439488 @default.
- W2123955897 cites W2164859692 @default.
- W2123955897 cites W2169724245 @default.
- W2123955897 cites W2221262359 @default.
- W2123955897 cites W2239877721 @default.
- W2123955897 cites W2248054795 @default.
- W2123955897 cites W2272635336 @default.
- W2123955897 cites W2275275367 @default.
- W2123955897 cites W2323490326 @default.
- W2123955897 cites W2326175431 @default.
- W2123955897 cites W2331176038 @default.
- W2123955897 cites W2332991185 @default.
- W2123955897 cites W2336211911 @default.
- W2123955897 cites W2336241188 @default.
- W2123955897 cites W2341259055 @default.
- W2123955897 cites W2341863517 @default.